Primary Care and Specialty Care Online CME/CE Courses for Physicians and Nurses for Medical License Renewal. Search by State and Specialty Course Bundles.
Jazzy Select Elite
The Jazzy Select Elite delivers a potent blend of power, performance and style. In-line, front-wheel drive technology gives the Elite excellent stability and maneuverability for solid performance indoors and out.
Jazzy Select Elite Features
Jazzy includes shroud and controller guards to protect against daily wear and tear.
Red or blue color-through shroud.
Black high-back seat with removable, replaceable back and seat covers.
Dual-layer powder coated frame for increased durability.
Larger foot platform.
40 amp, PG GC 3 controller.
Built with ease of service in mind.
Jazzy Select Elite Specifications
Weight Capacity: 300 lbs.
Turning Radius: 24.75"
Width: 22.75"
Length: 34.75"
Maximum Speed Up to 4 mph
Ground Clearance: 1.5"
Front Wheels: 3" solid anti-tips
Drive Wheels: 9" solid
Rear Wheels: 6" solid casters
Drivetrain: Two-motor, in-line, front-wheel drive
Braking System Regenerative and electro-mechanical
Suspension Type Limited
High-Back Seating: 20"W x 20"D (max. dimensions)
High-Back Seat-to-Floor Range: 21.5" - 23.5"
Specialty Seating: 20"W x 20"D (max. dimensions)
Specialty Seat-to-Floor Range: 16.5" - 18.5"
Synergy Seating 20"W x 20"D (max. dimensions)
Synergy Seat-to-Floor Range 17.25" - 19.25"
Standard Electronics: 40A, PG GC3
Battery Size: 12 volt, U-1 (2 required)
Standard Battery Charger: 3A, off-board
Per-Charge Range Up to 15 miles
Battery Weight: 24.5 lbs. each
Base Weight: 68.5 lbs.
Standard Seat Weight: 43 lbs. (comfort, high-back)
Standard Seat Size: 18" x 18"-20"
Fortis Hospital Gurgaon is a Multi Specialty in Hospital, Select doctors from the list of best doctors in Fortis Hospital and book appointment online only on credihealth. View specialties, procedure, education of doctors and consult with our in-house medical experts to select the best doctor in Fortis Hospital Gurgaon on Credihealth.com
An international specialty pharmaceutical group, Essential Pharma has announced the completion of two transactions with fellow UK-based Rosemont Pharmaceuticals.
The company completed the divestment of its oral liquid portfolio to Rosemont, and acquired a series of attractive, niche products with "geographic expansion potential."
Commenting on the announcement, Essential Pharma chief executive Steen Vangsgaard said: "The Rosemont products bring additional niche products into our portfolio with international expansion potential.
"The divestiture of our UK oral liquid products streamlines our portfolio, allowing us to focus and accelerate our strategic growth ambition of building a leading international specialty pharma platform."
Under the divestment deal, Rosemont Pharmaceuticals will acquire the product portfolio of licences, registrations and trademarks, as well as related commercial rights, to a number of oral generic products which are used to treat a range of conditions in various therapeutic areas.
Are you planning for some online shopping in this Christmas & New Year? Buy Snacks, Bars, Gluten free Foods, Drinks, Shakes and other speciality foods. Use speciality foods to lead a healthy lifestyle in the year, 2013. Get upto 18% off on best speciality food products.
Offer is valid till 31st December, 2012
http://www.health-shoppe.com/Specialty-Food/
Sun Pharmaceutical Industries, India's largest drugmaker by revenue, reported a better-than-expected 5.2 per cent rise in third-quarter profit on Tuesday,
driven by higher sales of its specialty drugs.
The company, known for its consumer healthcare products such as Revital vitamins and pain relief medicine Volini, said it earned a consolidated net profit of 21.66
billion rupees ($265.23 million) in three months ended Dec. 31, up from 20.59 billion rupees last year.
Analysts, on average, had expected the company to report a profit of 21.26 billion rupees, according to Refinitiv IBES data.
Total revenue from operations climbed nearly 14 per cent to 112.41 billion rupees. Input costs rose 8.5 per cent. Drug sales in India rose 7.1 per cent to 33.92
billion rupees, whereas sales in the United States climbed 16.6 per cent to 34.66 billion rupees, with each of the two regions accounting for 31 per cent of the
company's total consolidated sales.
The company, founded in 1983, makes over-the-counter medications, anti-retrovirals and active pharmaceutical ingredients for chronic and acute treatments.
Walgreens Boots Alliance, Boots UK's parent company, has appointed Tim Wentforth as its new CEO, effective on 23 October.
He joined WBA at a pivotal time when the company plans to downsize the business while driving execution and creating greater value for employees, patients,
customers and shareholders.
Wentforth replaced Rosalind Brewer, who stepped down on 1 September, after two years at the helm.
He joined from Evernorth, Cigna's health services organisation based in Connecticut, where he served as its founding CEO.
Prior to Cigna, he also held top roles in companies including specialty pharmacy company Accredo and pharmacy benefit manager Express Scripts.
Sehat.com have 79 doctors listed in All India Institute of Medical Sciences (AIIMS) with comprehensive information about the doctor including qualification, experience, education, procedures and conditions treated, expertise and more. You can search All India Institute of Medical Sciences (AIIMS) doctors list by name or specialty.
https://www.sehat.com/doctors-list/all-india-institute-of-medical-sciences-aiims-delhi
Recliner wheelchairs represent the highest standard in affordable quality, style and strength. The gray hammer tone finish is fashionable and durable. Comfortable padded black cloth material is re-enforced to prevent stretching and ripping. The high back includes a neck support to provide additional comfort for patient. The dual axle design allows for easy conversion from adult to hemi seat heights. They recline to full 180 degree positions, and have "Easy Adjust" foot riggings.
Obstetrics and gynaecology is the medical specialty dealing with fields of obstetrics and gynaecology through only one postgraduate training programme. This combined training prepares the practicing OB & GYN to be adapt at the care of female reproductive organs's health and at the management of obstetric complications even through surgery.
GlaxoSmithKline on Wednesday (April 13) said it had agreed to buy US group Sierra Oncology, a specialist in medicines for rare forms of cancer, for $1.9 billion.
The purchase, worth the equivalent of £1.6 billion, aims to support the development of new medicines alongside Sierra's bone marrow cancer treatment Momelotinib.
The deal, set to be completed this year, represents a near 40-percent premium to Sierra's closing share price on Tuesday, GSK said in a statement.
Momelotinib could help address the "significant unmet medical needs" of patients with the blood cancer myelofibrosis and anaemia, said GSK chief commercial officer
Luke Miels.
"With this proposed acquisition, we have the opportunity to potentially bring meaningful new benefits to patients and further strengthen our portfolio of specialty
medicines," he added.
HayMax, manufacturer of organic, drug-free allergen barrier balms for hay fever, dust, and pet allergies, has recently won the 2023 Global 100 awards. The
HayMax balm, applied around nostril rims and eye bones, is an innovative allergen blocker against pollen, dust, and pet allergens entering the body.
Independent university research confirms it traps over a third of pollen, along with dust mites and pet dander, before they enter the body, according to HayMax.
The drug-free balm is Soil Association-certified organic, comprising 100 per cent natural ingredients. Safe for children, pregnant, and breastfeeding women, it
holds the Vegetarian Society Approved trademark.
This award has come as a complete surprise to us at HayMax," said HayMax MD, Max Wiseberg. "Being held in such high regard through this global recognition is truly
delightful."
"The Global 100 aims to offer readers insight into firms that excel in their chosen specialties, and the award underscores hard work and innovation of various
companies," said its organisers.
The Recent Updates in Trauma and Emergency Medicine & webinar is organized by eMedEvents. Education on the latest developments & current best practices within the specialty
Kentucky Physicians State Board required Courses and Emergency Medicine & Pediatric Emergency Medicine Courses Bundle is organized by eMedEd, Inc. and will be held from Apr 04, 2022 - Aug 30, 2024. It encompasses a total of sixteen courses, addressing one mandatory topics specified by the Kentucky Physicians State Board and twelve courses specifically relevant to their respective specialties.
Enhance your medical knowledge and earn CME credits with our comprehensive Kentucky Primary Care Physicians & Internists CME Courses Bundle.
It encompasses seventeen courses, addressing one mandatory topic specified by the Kentucky Physicians State Board, and thirteen courses specifically relevant to their respective specialties.
In partnership with the pharmaceutical company Boehringer Ingelheim, Leeds Teaching Hospitals Trust (LTHT) has recently established an innovative
cardiometabolic clinic.
The clinic focuses on reducing cardiovascular risk in people with diabetes who have recently been discharged from LTHT following a heart attack. It is delivered jointly by the cardiology department at Leeds General Infirmary and the diabetes services at the Trust.
This is a patient-centred approach to reducing that risk, with pharmacist-delivered clinics scheduled for six to eight weeks after the heart attack.
Stephen Wheatcroft, Professor of Cardiometabolic Medicine and Consultant Cardiologist at LTHT, said: "This is an exciting and innovative development, one of the
first in the country. Previously, Type 2 diabetic patients presenting with heart issues would have been treated by two separate specialty teams. This is the first time there has been a specific clinic combining the cardiac and diabetes team working together.
"We aim to reduce the risk for patients, with earlier multidisciplinary hospital care, to help discharged patients achieve better diabetes control, through improved medication support and optimisation, reducing the need for further treatment and future hospital stays. Overall, it will mean a better patient experience, with improved monitoring and information about treatment options, along with a reduction in waiting times for review in a specialist clinic."